A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

Molecular Pharmacology of NRH:Quinone Oxidoreductase 2: A Detoxifying Enzyme Acting as an Undercover Toxifying Enzyme. | LitMetric

Molecular Pharmacology of NRH:Quinone Oxidoreductase 2: A Detoxifying Enzyme Acting as an Undercover Toxifying Enzyme.

Mol Pharmacol

Department of Health Sciences, Magna Graecia University, Campus Germaneto, Catanzaro, Italy (E.J.); Pharmadev, UMR 152, Université de Toulouse, IRD, UPS, Toulouse, France (F.N.); Sanofi - Strasbourg R&D Center, Strasbourg Cedex, France (B.C.); Institut de Recherches Servier, Croissy-sur-Seine, France (G.F.); and Institut de Recherches Internationales Servier, Suresnes Cedex, France (J.A.B.)

Published: November 2020

AI Article Synopsis

  • NQO2 (ribosyldihydronicotinamide:quinone oxidoreductase 2) is an enzyme found mainly in the liver and involved in reducing quinones, but it functions differently from its counterpart NQO1 by not utilizing NADH as a cofactor.
  • Recent studies suggest that rather than detoxifying, NQO2 may produce harmful reactive oxygen species through a futile cycle when reducing certain substrates, particularly -quinones.
  • Although NQO2 interactions with various drugs have been widely studied, its exact role in disease mechanisms remains under-explored, prompting a need for further research in molecular pharmacology.

Article Abstract

-ribosyldihydronicotinamide:quinone oxidoreductase 2 (NQO2/QR2, Enzyme Commission number 1.10.99.2) is a cytosolic enzyme, abundant in the liver and variably expressed in mammalian tissues. Cloned 30 years ago, it was characterized as a flavoenzyme catalyzing the reduction of quinones and pseudoquinones. To do so, it uses exclusively -alkyl nicotinamide derivatives, without being able to recognize NADH, the reference hydrure donor compound, in contrast to its next of a kind, NAD(P)H:quinone oxidoreductase 1 (NQO1). For a long time both enzymes have been considered as key detoxifying enzymes in quinone metabolism, but more recent findings point to a more toxifying function of NQO2, particularly with respect to -quinones. In fact, during the reduction of substrates, NQO2 generates fairly unstable intermediates that reoxidize immediately back to the original quinone, creating a futile cycle, the byproducts of which are deleterious reactive oxygen species. Beside this peculiarity, it is a target for numerous drugs and natural compounds such as melatonin, chloroquine, imiquimod, resveratrol, piceatannol, quercetin, and other flavonoids. Most of these enzyme-ligand interactions have been documented by numerous crystallographic studies, and now NQO2 is one of the best represented proteins in the structural biology database. Despite evidence for a causative role in several important diseases, the functional role of NQO2 remains poorly explored. In the present review, we aimed at detailing the main characteristics of NQO2 from a molecular pharmacology perspective. By drawing a clear border between facts and speculations, we hope to stimulate the future research toward a better understanding of this intriguing drug target. SIGNIFICANCE STATEMENT: Evidence is reviewed on the prevalent toxifying function of -ribosyldihydronicotinamide:quinone oxidoreductase 2 while catalyzing the reduction of -quinones such as dopamine quinone. The product of this reaction is unstable and generates a futile but harmful cycle (substrate/product/substrate) associated with reactive oxygen species generation.

Download full-text PDF

Source
http://dx.doi.org/10.1124/molpharm.120.000105DOI Listing

Publication Analysis

Top Keywords

molecular pharmacology
8
-ribosyldihydronicotinamidequinone oxidoreductase
8
catalyzing reduction
8
toxifying function
8
reactive oxygen
8
oxygen species
8
nqo2
5
pharmacology nrhquinone
4
oxidoreductase
4
nrhquinone oxidoreductase
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!